- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Digipath Labs Reports on Two Cannabis Strains With Cannabinoid Levels Over 30 Percent
DigiPath (OTCQB:DIGP) reported that two cannabis strains tested in its Las Vegas lab had returned cannibinoid levels of over 30 percent. The two strains, Headcheese and True OG, were cultivated by Nevada’s Polaris MMJ.
DigiPath (OTCQB:DIGP) reported that two cannabis strains tested in its Las Vegas lab had returned cannibinoid levels of over 30 percent. The two strains, Headcheese and True OG, were cultivated by Nevada’s Polaris MMJ.
As quoted in the press release:
After analyzing over six hundred cannabis flower samples, two separate cured cannabis flower samples were certified at 35.1% and 37.5% total cannabinoid content. The two strains in question, Headcheese and True OG, are new arrivals to the Las Vegas medical marijuana community through the cultivating efforts of Polaris MMJ. Cannabinoid levels coming in over 30% are unique, not just in Vegas but across the country.
A closer look at the breakdown of cannabinoids in these two strains reveals two unique profiles. The hybrid Headcheese strain produced not only a remarkable 31.35% THCA but an even lesser seen level of 2.46% CBGA, the chemical precursor molecule of both THCA and CBDA; while True OG came in with a whopping 35.9% THCA. From the terpenoid profiles, we observed high levels of myrcene (think mango, lemongrass, relaxed, happy) and isopulegol (the precursor to menthol) in the Headcheese strain while the True OG strain also had notable myrcene, limonene (love lemon) and linalool (anti-epileptic, lavender).
Digipath Labs Chief Science Officer, Cindy Orser, said:
Headcheese, a sativa-indica hybrid strain has attracted followings across the country due to its impressive THCA levels attributed to its astonishing analgesic benefits to alleviate migraines, inflammation, spasms and insomnia. The cured yellow-green brain-shaped flower buds have a lemon, pine, and cheese aroma leaving an earthy not fruity taste. The cheese-head effects are reportedly a total mind body experience, both relaxing and euphoric.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.